Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





MONOCROTOPHOS								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 6923-22-4; **Chemical Formula:** C7H14NO5P
OSHA formerly had no limit for the systemic insecticide monocrotophos. The ACGIH has a TLV-TWA of 0.25 mg/m3 for this reddish-brown solid with a mild ester odor. The proposed PEL was 0.25 mg/m3 as an 8-hour TWA; NIOSH (Ex. 8-47, Table N1) concurs with this limit, which is established in the final rule.
Monocrotophos is a highly toxic, direct acting cholinesterase inhibitor that penetrates the intact skin (ACGIH 1986/Ex. 1-3, p. 416). The acute oral LD(50) values in rats and mice range from 5.7 to 17 mg/kg in a water formulation (Brown et al. 1970, Shellenberger and Newell, both as cited in ACGIH 1986/Ex. 1-3, p. 416) and from 10 to 23 mg/kg in an oil formulation (Shellenberger and Newell, as cited in ACGIH 1986/Ex. 1-3, p. 416). These authors also report a percutaneous LD(50) in the rabbit that ranges from 112 to 709 mg/kg, depending on the vehicle used. A two-year dietary study of rats ingesting 0, 1, 10, or 100 ppm monocrotophos revealed that both sexes in the 100 ppm group failed to gain as much weight as the controls, but autopsy showed no significant findings; plasma, erythrocyte, and brain cholinesterase decreased at the two highest dose levels but were unaffected at 1 ppm (Johnston 1966-67, as cited in ACGIH 1986/Ex. 1-3, p. 416). Another two-year feeding study in dogs administered doses of up to 16 ppm monocrotophos revealed no adverse effects at levels of 0.16 and 1.6 ppm, but serious cholinesterase reduction was observed at the 16-ppm level (Johnston 1966-67, as cited in ACGIH 1986/Ex. 1-3, p. 416). Metabolism studies in rats and goats indicate that monocrotophos is excreted rapidly in the rat and does not accumulate in the body (Bull and Lindquist 1966/Ex 1-719); goats given labeled monocrotophos by mouth showed only traces of the material in their milk (Menzer and Casida 1965/Ex. 1-986; Potter, as cited in ACGIH 1986/Ex. 1-3, p. 416). Inhalation exposure of rats to an unknown concentration of 75 percent monocrotophos in air for one hour was not lethal; a four-hour exposure to an unknown concentration of the aerosol (0.4 and 0.75 percent) was fatal to two out of six (0.4 percent aerosol) and five out of eight rats (0.75 percent aerosol). Head-only exposure to the 0.4-percent aerosol resulted in the death of one of eight animals (Wilson, as cited in ACGIH 1986/Ex. 1-3, p. 416).
Intravenous injection of radiolabeled monocrotophos in human volunteers showed maximum excretion at 4 to 8 hours, with 67 + 5 percent of the material in the urine; absorption of 14 + 7 percent occurred when the radiolabeled material was applied to the forearm; 33 + 9 percent of the applied dose was absorbed when it was covered with a vapor-proof film for 72 hours (Maibach 1970, as cited in ACGIH 1986/Ex. 1-3, p. 416). Although gauze patches attached to the clothing and skin of field workers attested to the presence of monocrotophos, no cholinesterase inhibition was observed in post-exposure examinations at three hours and at three and seven days (Maibach, as cited in ACGIH 1986/Ex. 1-3, p. 416). Only NIOSH commented on this substance.
OSHA is establishing a PEL of 0.25 mg/m3 (8-hour TWA) for monocrotophos in the final rule.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue